title: Engineered CRISPR/Cas13d Virus-Like Particles for Potent, Safe Gene Therapy of Idiopathic Pulmonary Fibrosis
design: Mouse were injected with PBS into the trachea every two days, for a total of four injections. On day 7, lung tissues were collected for sequencing. The samples were divided into three parts for sequencing.